Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae (TEA)

This study has been withdrawn prior to enrollment.
(No patient has been included in 9 months because of strict incl/excl criteria)
Sponsor:
Information provided by (Responsible Party):
Belpharma s.a.
ClinicalTrials.gov Identifier:
NCT01543347
First received: February 22, 2012
Last updated: January 28, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)